Juanjuan Shi
Zhenjiang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
CD47/SIRPα Axis in Cancer Immunotherapy: Mechanisms, Regulation, and Therapeutic Strategies.
Journal: European journal of pharmacology
Published: April 05, 2026
The dual roles of CD24 in tumorigenesis and immune evasion.
Journal: Molecular immunology
Published: January 11, 2026
Clofibrate inhibits tumor immune escape by increasing macrophage phagocytosis.
Journal: European journal of pharmacology
Published: January 02, 2026
Metformin suppresses PPARδ-driven CD47 transcription to enhance macrophage phagocytosis in lung cancer.
Journal: The Journal of biological chemistry
Published: August 06, 2025
TBB inhibits CK2/PD-L1/EGFR pathway-mediated tumor progression.
Journal: European journal of pharmacology
Published: January 26, 2025
GW501516 facilitated tumor immune escape by inhibiting phagocytosis.
Journal: European journal of pharmacology
Published: November 11, 2024
Ubiquitination of CD47 Regulates Innate Anti-Tumor Immune Response.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 01, 2024
PPARδ Antagonist Inhibited CD47 Expression and Phagocytosis.
Journal: Journal of cellular biochemistry
Published: August 26, 2024
NF-κB role on tumor proliferation, migration, invasion and immune escape.
Journal: Cancer gene therapy
Published: April 16, 2024
GSK0660 enhances antitumor immunotherapy by reducing PD-L1 expression.
Journal: European journal of pharmacology
Published: January 10, 2024
Dual function of activated PPARγ by ligands on tumor growth and immunotherapy.
Journal: Medical oncology (Northwood, London, England)
Published: January 10, 2024
PPARα phosphorylation regulates colorectal tumor immune escape.
Journal: The Journal of biological chemistry
Published: January 06, 2024
Last Updated: 09/26/2026